The promising results from trials of a malaria vaccine developed by GlaxoSmithKline have kindled hopes of a breakthrough in combating this mosquito-transmitted disease that infects nearly 250 million people, killing about a million every year.
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/malaria-vaccine-1
[2] http://admin.indiaenvironmentportal.org.in/category/newspaper/business-standard-new-delhi
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/malaria
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/medical-research
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/immunisation
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/vaccination
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/who
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/kenya
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/tanzania
